Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Phlebotomy × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 4 Interventional 1

Sponsor

Cancer Type

Myeloid 4 Thoracic 1 Sarcoma 1 Other hematologic neoplasm 1 Gastrointestinal 1

Conditions

Liver Neoplasms 1

Interventions

Oxaliplatin 1171 Fluorouracil 1094 Capecitabine 895 Gemcitabine 867 Leucovorin 776 Irinotecan 680 Bevacizumab 654 Cisplatin 556 Radiotherapy 461 Cetuximab 390 pembrolizumab 359 Paclitaxel 329 Nivolumab 271 Drug Therapy 265 130-nm albumin-bound paclitaxel 257 Docetaxel 251 Sorafenib 236 S 1 (combination) 232 Folfox protocol 219 Albumin-Bound Paclitaxel 204 Surgical Procedures, Operative 178 durvalumab 177 apatinib 173 lenvatinib 167 tislelizumab 165 Radiosurgery 165 sintilimab 163 Carboplatin 152 Radiation 151 regorafenib 144

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548910 2021-03-18

PRICE

Ottawa Hospital Research Institute

Phase NA Completed

62 enrolled 13 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡